Searched for
DRUG REGULATION
India needs policy predictability to speed up drug approvals and boost pharma innovation: OPPI DGAnil Matai from the Organisation of Pharmaceutical Producers of India emphasized the need for regulatory predictability. He noted that Indi...
DRI searches Cipla's Mumbai office, Bhiwandi depot over imported drugsThe Directorate of Revenue Intelligence's Mumbai zonal unit has searched Cipla's office in Vikhroli and its depot in Bhiwandi over the clas...
US stocks: Summit shares drop after US FDA declines to approve lung cancer drugSummit Therapeutics faced a notable decline in share value following the FDA's ruling on ivonescimab, which revealed insufficient overall s...
USFDA closes inspection of Dr Reddy's Hyderabad facility with VAI statusDr Reddy's Laboratories announced that the USFDA classified the outcome of its inspection as 'Voluntary Action Indicated'. This classificat...
Compulsory licensing of drugs only after exhausting all other measures: Department of Pharmaceuticals secretary Manoj JoshiThe government plans to address the high costs of innovative medicines by first negotiating prices. Compulsory licensing will be considered...
Made in Pakistan beauty products seized in Maharashtra leave officials stunned: One cream found with 48,453 times the permissible mercury limitTwo Pakistani-labelled beauty creams seized by Nanded police have been found to contain dangerously high levels of mercury, with concentrat...
India may open doors to multinational pharma firms for first-in-human Phase I trialsIndia is considering modifications to its pharmaceutical regulatory framework to attract multinational companies for clinical trials. Discu...
USFDA classifies Aurobindo Pharma's US facility as 'official action indicated'The facility belongs to Lannett Company LLC, a wholly owned step-down subsidiary of Aurobindo Pharma. The US Food and Drug Administration (...
Aurobindo Pharma arm gets 'Voluntary Action Indicated' classification for Telengana facility from USFDAFollowing an inspection from September 7 to September 15, 2026, the US FDA granted Apitoria Pharma, a subsidiary of Aurobindo Pharma, a Vol...
GLP-1 drugs for weight loss Ozempic, Wegovy linked to vision loss: What is NAION, who is at risk and what symptoms should users watch for?Side effects of weight loss drugs: The makers of GLP-1 weight loss drugs such as Ozempic, Wegovy and Mounjaro must add a warning label abou...
US FDA adds rare vision-loss warning to popular GLP-1 drugsThe US FDA will add a warning about a rare eye condition that can cause permanent vision loss to the labels of all GLP-1 drugs, including O...
India, US vow to jointly act against emerging drug threatsIndia and the US have agreed to strengthen cooperation against emerging narcotics threats, including illicit drug trafficking and the diver...
Over 1,300 anti-cancer drugs to get cheaperIndia's National Pharmaceutical Pricing Authority is set to cap trade margins on anti-cancer drugs starting November 2026. The initiative a...
Cancer drug prices revised from today; patients may save Rs 3,540 crore annuallyThe government has revised the prices of 1,364 anti-cancer medicine formulations effective from November 9. This decision aims to limit tra...
Centre proposes 10 new entry points for drug imports into India, Noida airport includedThe Centre has proposed expanding India's authorised import network for pharmaceuticals and medical devices by adding ten new locations. Th...
Govt plans instant ban on manufacturing of drugs failing key quality testsPharma companies could have their drug licenses suspended immediately if quality tests indicate failure. The health ministry's proposed cha...
Wockhardt seeks 14-year data shield for India-made drugsMumbai-based Wockhardt has struck success in its innovative research on a range of antibiotic drugs, bridging a global pipeline gap for dif...